SMF
WST icon

Scott Marsh Financial’s West Pharmaceutical WST Stock Holding History

Scott Marsh Financial’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$1.29M Buy
+5,906
New +$1.26M 0.48% 60

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Scott Marsh Financial's WST Position: Q2 2025 in Review

Scott Marsh Financial opened a new position in West Pharmaceutical (WST) in Q2 2025: 5,906 shares worth $1.29M. The stake represents 0.48% of the portfolio and ranks #60 among its holdings.

730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • Scott Marsh Financial held 5,906 shares of West Pharmaceutical worth $1.29M as of Q2 2025.
  • West Pharmaceutical was a new Scott Marsh Financial position in Q2 2025.
  • West Pharmaceutical made up 0.48% of Scott Marsh Financial's portfolio in Q2 2025, its #60 holding.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on Scott Marsh Financial's 13F filing for Q2 2025, filed 14 Aug 2025.